Find Grants for Advance Search

Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.

$ 100 Trillion
Total Dollars Available

Geospace Cluster

No deadline specified


Opportunity Number: PD-24-7789

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

Infrastructure Cluster

No deadline specified


Opportunity Number: PD-24-7791

Agency: U.S. National Science Foundation

Open Date: September 26, 2024

Status: Posted

CFDA Numbers: 47.050

RESTORE Act Centers of Excellence Research Grants Program

Deadline: October 31, 2026


Opportunity Number: GR-RCE-25-001

Agency: U.S. Dept. of Treasury RESTORE Act Program

Open Date: September 26, 2024

Close Date: October 31, 2026

Status: Posted

CFDA Numbers: 21.015

RESTORE Act Direct Component – Construction and Real Property Acquisition Activities

Deadline: October 31, 2026


Opportunity Number: GR-RDC-25-001

Agency: U.S. Dept. of Treasury RESTORE Act Program

Open Date: September 26, 2024

Close Date: October 31, 2026

Status: Posted

CFDA Numbers: 21.015

RESTORE Act Direct Component - Non-Construction Activities

Deadline: October 31, 2026


Opportunity Number: GR-RDC-25-002

Agency: U.S. Dept. of Treasury RESTORE Act Program

Open Date: September 26, 2024

Close Date: October 31, 2026

Status: Posted

CFDA Numbers: 21.015

BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)

Deadline: June 15, 2027


Opportunity Number: RFA-MH-26-120

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: June 15, 2027

Status: Posted

CFDA Numbers: 93.213, 93.867, 93.853, 93.286, 93.865, 93.242, 93.279, 93.273, 93.866, 93.173

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

Deadline: August 18, 2026


Opportunity Number: PAR-25-051

Agency: National Institutes of Health

Open Date: September 25, 2024

Close Date: August 18, 2026

Status: Posted

CFDA Numbers: 93.121, 93.867, 93.279, 93.853, 93.242, 93.273, 93.213, 93.866

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)

Deadline: June 16, 2026


Opportunity Number: RFA-NS-25-018

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: June 16, 2026

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.865, 93.286, 93.853, 93.867, 93.866, 93.173, 93.213, 93.273

BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)

Deadline: June 16, 2026


Opportunity Number: RFA-NS-25-017

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: June 16, 2026

Status: Posted

CFDA Numbers: 93.279, 93.242, 93.865, 93.286, 93.853, 93.867, 93.866, 93.173, 93.213, 93.273

NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)

Deadline: September 25, 2027


Opportunity Number: PAR-24-301

Agency: National Institutes of Health

Open Date: September 24, 2024

Close Date: September 25, 2027

Status: Posted

CFDA Numbers: 93.865

Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)

Deadline: September 9, 2027


Opportunity Number: PAR-24-298

Agency: National Institutes of Health

Open Date: September 20, 2024

Close Date: September 9, 2027

Status: Posted

CFDA Numbers: 93.279

Safety, Security, and Privacy of Open-Source Ecosystems

Deadline: April 28, 2026


Opportunity Number: 24-608

Agency: U.S. National Science Foundation

Open Date: September 20, 2024

Close Date: April 28, 2026

Status: Posted

CFDA Numbers: 47.074, 47.075, 47.041, 47.076, 47.049, 47.083, 47.050, 47.070, 47.084, 47.079

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Deadline: January 15, 2027


Opportunity Number: RFA-NS-25-023

Agency: National Institutes of Health

Open Date: September 18, 2024

Close Date: January 15, 2027

Status: Posted

CFDA Numbers: 93.846, 93.121, 93.213, 93.273, 93.847, 93.865, 93.393, 93.866, 93.853, 93.867

Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-24-297

Agency: National Institutes of Health

Open Date: September 17, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.279

Multilateral Partnerships Leveraging Excellence

No deadline specified


Opportunity Number: PD-24-7298

Agency: U.S. National Science Foundation

Open Date: September 14, 2024

Status: Posted

CFDA Numbers: 47.079

Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)

Deadline: July 14, 2026


Opportunity Number: PAR-24-275

Agency: National Institutes of Health

Open Date: September 11, 2024

Close Date: July 14, 2026

Status: Posted

CFDA Numbers: 93.213

Automated Processes for Knowledge Discovery and Information Retrieval

Deadline: September 9, 2029


Opportunity Number: FA875024S7006

Agency: Air Force -- Research Lab

Open Date: September 9, 2024

Close Date: September 9, 2029

Status: Posted

CFDA Numbers: 12.800, 12.910

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-043

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.399, 93.393, 93.396

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-044

Agency: National Institutes of Health

Open Date: September 5, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393, 93.396, 93.399

Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Deadline: September 28, 2027


Opportunity Number: PAR-24-272

Agency: National Institutes of Health

Open Date: September 3, 2024

Close Date: September 28, 2027

Status: Posted

CFDA Numbers: 93.350

Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T32)

Deadline: January 25, 2027


Opportunity Number: PAR-24-235

Agency: National Institutes of Health

Open Date: September 3, 2024

Close Date: January 25, 2027

Status: Posted

CFDA Numbers: 93.859

Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program (UE5/T34)

Deadline: January 25, 2027


Opportunity Number: PAR-24-236

Agency: National Institutes of Health

Open Date: September 3, 2024

Close Date: January 25, 2027

Status: Posted

CFDA Numbers: 93.859

NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)

Deadline: May 25, 2026


Opportunity Number: PAR-24-281

Agency: National Institutes of Health

Open Date: August 28, 2024

Close Date: May 25, 2026

Status: Posted

CFDA Numbers: 93.879, 93.313

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-24-273

Agency: National Institutes of Health

Open Date: August 27, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.307, 93.361, 93.866, 93.393

NOAA Great Lakes Fish Habitat Restoration Partnership Grants

No deadline specified


Opportunity Number: NOAA-NMFS-HCPO-2024-28122

Agency: DOC NOAA - ERA Production

Open Date: August 27, 2024

Status: Posted

CFDA Numbers: 11.463

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.